Limitation of myocardial infarct size. Present status.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004562:Electrocardiography; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000473:pathology; D011188:Potassium / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D007328:Insulin; D014665:Vasodilator Agents; C030396:glucose-insulin-potassium cardioplegic solution; D006821:Hyaluronoglucosaminidase; D013300:Streptokinase; D005947:Glucose; D011188:Potassium